Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques

Nicholas J. Maness, Levi J. Yant, Chungwon Chung, John T. Loffredo, Thomas C. Friedrich, Shari M. Piaskowski, Jessica Furlott, Gemma E. May, Taeko Soma, Enrique J. León, Nancy A. Wilson, Helen Piontkivska, Austin L. Hughes, John Sidney, Alessandro Sette, David Watkins

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The association between particular major histocompatibility complex class I (MHC-I) alleles and control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication implies that certain CD8+ T-lymphocyte (CD8-TL) responses are better able than others to control viral replication in vivo. However, possession of favorable alleles does not guarantee improved prognosis or viral control. In rhesus macaques, the MHC-I allele Mamu-B*17 is correlated with reduced viremia and is overrepresented in macaques that control SIVmac239, termed elite controllers (ECs). However, there is so far no mechanistic explanation for this phenomenon. Here we show that the chronic-phase Mamu-B*17-restricted repertoire is focused primarily against just five epitopes - VifHW8, EnvFW9, NefIW9, NefMW9, and envARFcRW9 - in both ECs and progressors. Interestingly, Mamu-B*17-restricted CD8-TL do not target epitopes in Gag. CD8-TL escape variation occurred in all targeted Mamu-B*17-restricted epitopes. However, recognition of escape variant peptides was commonly observed in both ECs and progressors. Wild-type sequences in the VifHW8 epitope tended to be conserved in ECs, but there was no evidence that this enhances viral control. In fact, no consistent differences were detected between ECs and progressors in any measured parameter. Our data suggest that the narrowly focused Mamu-B*17-restricted repertoire suppresses virus replication and drives viral evolution. It is, however, insufficient in the majority of individuals that express the "protective" Mamu-B*17 molecule. Most importantly, our data indicate that the important differences between Mamu-B*17-positive ECs and progressors are not readily discernible using standard assays to measure immune responses.

Original languageEnglish
Pages (from-to)5245-5254
Number of pages10
JournalJournal of Virology
Volume82
Issue number11
DOIs
StatePublished - Jun 1 2008
Externally publishedYes

Fingerprint

Simian immunodeficiency virus
Simian Immunodeficiency Virus
Macaca mulatta
Epitopes
epitopes
Alleles
Virus Replication
virus replication
Major Histocompatibility Complex
T-Lymphocytes
T-lymphocytes
major histocompatibility complex
alleles
Viremia
Macaca
viremia
Human immunodeficiency virus
HIV
Peptides
prognosis

ASJC Scopus subject areas

  • Immunology

Cite this

Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques. / Maness, Nicholas J.; Yant, Levi J.; Chung, Chungwon; Loffredo, John T.; Friedrich, Thomas C.; Piaskowski, Shari M.; Furlott, Jessica; May, Gemma E.; Soma, Taeko; León, Enrique J.; Wilson, Nancy A.; Piontkivska, Helen; Hughes, Austin L.; Sidney, John; Sette, Alessandro; Watkins, David.

In: Journal of Virology, Vol. 82, No. 11, 01.06.2008, p. 5245-5254.

Research output: Contribution to journalArticle

Maness, NJ, Yant, LJ, Chung, C, Loffredo, JT, Friedrich, TC, Piaskowski, SM, Furlott, J, May, GE, Soma, T, León, EJ, Wilson, NA, Piontkivska, H, Hughes, AL, Sidney, J, Sette, A & Watkins, D 2008, 'Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques', Journal of Virology, vol. 82, no. 11, pp. 5245-5254. https://doi.org/10.1128/JVI.00292-08
Maness, Nicholas J. ; Yant, Levi J. ; Chung, Chungwon ; Loffredo, John T. ; Friedrich, Thomas C. ; Piaskowski, Shari M. ; Furlott, Jessica ; May, Gemma E. ; Soma, Taeko ; León, Enrique J. ; Wilson, Nancy A. ; Piontkivska, Helen ; Hughes, Austin L. ; Sidney, John ; Sette, Alessandro ; Watkins, David. / Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques. In: Journal of Virology. 2008 ; Vol. 82, No. 11. pp. 5245-5254.
@article{75c55089a0564b27a44ceaae3d18c99b,
title = "Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques",
abstract = "The association between particular major histocompatibility complex class I (MHC-I) alleles and control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication implies that certain CD8+ T-lymphocyte (CD8-TL) responses are better able than others to control viral replication in vivo. However, possession of favorable alleles does not guarantee improved prognosis or viral control. In rhesus macaques, the MHC-I allele Mamu-B*17 is correlated with reduced viremia and is overrepresented in macaques that control SIVmac239, termed elite controllers (ECs). However, there is so far no mechanistic explanation for this phenomenon. Here we show that the chronic-phase Mamu-B*17-restricted repertoire is focused primarily against just five epitopes - VifHW8, EnvFW9, NefIW9, NefMW9, and envARFcRW9 - in both ECs and progressors. Interestingly, Mamu-B*17-restricted CD8-TL do not target epitopes in Gag. CD8-TL escape variation occurred in all targeted Mamu-B*17-restricted epitopes. However, recognition of escape variant peptides was commonly observed in both ECs and progressors. Wild-type sequences in the VifHW8 epitope tended to be conserved in ECs, but there was no evidence that this enhances viral control. In fact, no consistent differences were detected between ECs and progressors in any measured parameter. Our data suggest that the narrowly focused Mamu-B*17-restricted repertoire suppresses virus replication and drives viral evolution. It is, however, insufficient in the majority of individuals that express the {"}protective{"} Mamu-B*17 molecule. Most importantly, our data indicate that the important differences between Mamu-B*17-positive ECs and progressors are not readily discernible using standard assays to measure immune responses.",
author = "Maness, {Nicholas J.} and Yant, {Levi J.} and Chungwon Chung and Loffredo, {John T.} and Friedrich, {Thomas C.} and Piaskowski, {Shari M.} and Jessica Furlott and May, {Gemma E.} and Taeko Soma and Le{\'o}n, {Enrique J.} and Wilson, {Nancy A.} and Helen Piontkivska and Hughes, {Austin L.} and John Sidney and Alessandro Sette and David Watkins",
year = "2008",
month = "6",
day = "1",
doi = "10.1128/JVI.00292-08",
language = "English",
volume = "82",
pages = "5245--5254",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive simian immunodeficiency virus-infected rhesus macaques

AU - Maness, Nicholas J.

AU - Yant, Levi J.

AU - Chung, Chungwon

AU - Loffredo, John T.

AU - Friedrich, Thomas C.

AU - Piaskowski, Shari M.

AU - Furlott, Jessica

AU - May, Gemma E.

AU - Soma, Taeko

AU - León, Enrique J.

AU - Wilson, Nancy A.

AU - Piontkivska, Helen

AU - Hughes, Austin L.

AU - Sidney, John

AU - Sette, Alessandro

AU - Watkins, David

PY - 2008/6/1

Y1 - 2008/6/1

N2 - The association between particular major histocompatibility complex class I (MHC-I) alleles and control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication implies that certain CD8+ T-lymphocyte (CD8-TL) responses are better able than others to control viral replication in vivo. However, possession of favorable alleles does not guarantee improved prognosis or viral control. In rhesus macaques, the MHC-I allele Mamu-B*17 is correlated with reduced viremia and is overrepresented in macaques that control SIVmac239, termed elite controllers (ECs). However, there is so far no mechanistic explanation for this phenomenon. Here we show that the chronic-phase Mamu-B*17-restricted repertoire is focused primarily against just five epitopes - VifHW8, EnvFW9, NefIW9, NefMW9, and envARFcRW9 - in both ECs and progressors. Interestingly, Mamu-B*17-restricted CD8-TL do not target epitopes in Gag. CD8-TL escape variation occurred in all targeted Mamu-B*17-restricted epitopes. However, recognition of escape variant peptides was commonly observed in both ECs and progressors. Wild-type sequences in the VifHW8 epitope tended to be conserved in ECs, but there was no evidence that this enhances viral control. In fact, no consistent differences were detected between ECs and progressors in any measured parameter. Our data suggest that the narrowly focused Mamu-B*17-restricted repertoire suppresses virus replication and drives viral evolution. It is, however, insufficient in the majority of individuals that express the "protective" Mamu-B*17 molecule. Most importantly, our data indicate that the important differences between Mamu-B*17-positive ECs and progressors are not readily discernible using standard assays to measure immune responses.

AB - The association between particular major histocompatibility complex class I (MHC-I) alleles and control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication implies that certain CD8+ T-lymphocyte (CD8-TL) responses are better able than others to control viral replication in vivo. However, possession of favorable alleles does not guarantee improved prognosis or viral control. In rhesus macaques, the MHC-I allele Mamu-B*17 is correlated with reduced viremia and is overrepresented in macaques that control SIVmac239, termed elite controllers (ECs). However, there is so far no mechanistic explanation for this phenomenon. Here we show that the chronic-phase Mamu-B*17-restricted repertoire is focused primarily against just five epitopes - VifHW8, EnvFW9, NefIW9, NefMW9, and envARFcRW9 - in both ECs and progressors. Interestingly, Mamu-B*17-restricted CD8-TL do not target epitopes in Gag. CD8-TL escape variation occurred in all targeted Mamu-B*17-restricted epitopes. However, recognition of escape variant peptides was commonly observed in both ECs and progressors. Wild-type sequences in the VifHW8 epitope tended to be conserved in ECs, but there was no evidence that this enhances viral control. In fact, no consistent differences were detected between ECs and progressors in any measured parameter. Our data suggest that the narrowly focused Mamu-B*17-restricted repertoire suppresses virus replication and drives viral evolution. It is, however, insufficient in the majority of individuals that express the "protective" Mamu-B*17 molecule. Most importantly, our data indicate that the important differences between Mamu-B*17-positive ECs and progressors are not readily discernible using standard assays to measure immune responses.

UR - http://www.scopus.com/inward/record.url?scp=43949088824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949088824&partnerID=8YFLogxK

U2 - 10.1128/JVI.00292-08

DO - 10.1128/JVI.00292-08

M3 - Article

VL - 82

SP - 5245

EP - 5254

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 11

ER -